.png)
Rare Disease Genetic Testing Market by Technology and Application - Global Industry Analysis & Forecast to 2027
Published On : August 2020 Pages : 150 Category: Pharma & Healthcare Report Code : HC0812331
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Rare Disease Genetic Testing Market by Technology (Next-Generation Sequencing (NGS), Array Technology, PCR-based Testing, FISH, Sanger Sequencing, Karyotyping) Application (Research Laboratories & CROs, Diagnostic Laboratories, Hospitals & Clinics) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Rare Disease Genetic Testing Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Rare Disease Genetic Test identify the inherited disease conditions by analysing genes associated with known clinical phenotypes for presence of mutations.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Quest Diagnostics Inc.
- Centogene N.V.
- Invitae Corporation
- 3billion, Inc.
- Arup Laboratories
- Eurofins Scientific
- Strand Life Sciences
- Ambry Genetics
- Perkin Elmer, Inc.
- Macrogen, Inc.
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Rare Disease Genetic Testing Market, By Technology, Estimates and Forecast, 2017-2027 ($Million)
o Next-Generation Sequencing (NGS)
o Array Technology
o PCR-based Testing
o FISH
o Sanger Sequencing
o Karyotyping
· Rare Disease Genetic Testing Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
o Research Laboratories & CROs
o Diagnostic Laboratories
o Hospitals & Clinics
· Rare Disease Genetic Testing Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Quest Diagnostics Inc.
o Centogene N.V.
o Invitae Corporation
o 3billion, Inc.
o Arup Laboratories
o Eurofins Scientific
o Strand Life Sciences
o Ambry Genetics
o Perkin Elmer, Inc.
o Macrogen, Inc.
· Rare Disease Genetic Testing Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Rare Disease Genetic Testing Market , By Country
o U.S. Rare Disease Genetic Testing Market
o Canada Rare Disease Genetic Testing Market
o Mexico Rare Disease Genetic Testing Market
o Europe
§ Europe Rare Disease Genetic Testing Market , By Country
o Germany Rare Disease Genetic Testing Market
o UK Rare Disease Genetic Testing Market
o France Rare Disease Genetic Testing Market
o Russia Rare Disease Genetic Testing Market
o Italy Rare Disease Genetic Testing Market
o Rest of Europe Rare Disease Genetic Testing Market
o Asia-Pacific
§ Asia-Pacific Rare Disease Genetic Testing Market , By Country
o China Rare Disease Genetic Testing Market
o Japan Rare Disease Genetic Testing Market
o South Korea Rare Disease Genetic Testing Market
o India Rare Disease Genetic Testing Market
o Southeast Asia Rare Disease Genetic Testing Market
o Rest of Asia-Pacific Rare Disease Genetic Testing Market
o South America
§ South America Rare Disease Genetic Testing Market , By Country
o Brazil Rare Disease Genetic Testing Market
o Argentina Rare Disease Genetic Testing Market
o Columbia Rare Disease Genetic Testing Market
o Rest of South America Rare Disease Genetic Testing Market
o Middle East and Africa
§ Middle East and Africa Rare Disease Genetic Testing Market , By Country
o Saudi Arabia Rare Disease Genetic Testing Market
o UAE Rare Disease Genetic Testing Market
o Egypt Rare Disease Genetic Testing Market
o Nigeria Rare Disease Genetic Testing Market
o South Africa Rare Disease Genetic Testing Market
o Rest of MEA Rare Disease Genetic Testing Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Rare Disease Genetic Testing Market, By Technology
5.1. Introduction
5.2. Global Rare Disease Genetic Testing Revenue and Market Share by Technology (2017-2021)
5.2.1. Global Rare Disease Genetic Testing Revenue and Revenue Share by Technology (2017-2021)
5.3. Next-Generation Sequencing (NGS)
5.3.1. Global Next-Generation Sequencing (NGS) Revenue and Growth Rate (2017-2021)
5.4. Array Technology
5.4.1. Global Array Technology Revenue and Growth Rate (2017-2021)
5.5. PCR-based Testing
5.5.1. Global PCR-based Testing Revenue and Growth Rate (2017-2021)
5.6. FISH
5.6.1. Global FISH Revenue and Growth Rate (2017-2021)
5.7. Sanger Sequencing
5.7.1. Global Sanger Sequencing Revenue and Growth Rate (2017-2021)
5.8. Karyotyping
5.8.1. Global Karyotyping Revenue and Growth Rate (2017-2021)
6. Rare Disease Genetic Testing Market, By Applications
6.1. Introduction
6.2. Global Rare Disease Genetic Testing Revenue and Market Share by Applications (2017-2021)
6.2.1. Global Rare Disease Genetic Testing Revenue and Revenue Share by Applications (2017-2021)
6.3. Research Laboratories & CROs
6.3.1. Global Research Laboratories & CROs Revenue and Growth Rate (2017-2021)
6.4. Diagnostic Laboratories
6.4.1. Global Diagnostic Laboratories Revenue and Growth Rate (2017-2021)
6.5. Hospitals & Clinics
6.5.1. Global Hospitals & Clinics Revenue and Growth Rate (2017-2021)
7. Rare Disease Genetic Testing Market, By Region
7.1. Introduction
7.2. Global Rare Disease Genetic Testing Revenue and Market Share by Regions
7.2.1. Global Rare Disease Genetic Testing Revenue by Regions (2017-2021)
7.3. North America Rare Disease Genetic Testing by Countries
7.3.1. North America Rare Disease Genetic Testing Revenue and Growth Rate (2017-2021)
7.3.2. North America Rare Disease Genetic Testing Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe Rare Disease Genetic Testing by Countries
7.4.1. Europe Rare Disease Genetic Testing Revenue and Growth Rate (2017-2021)
7.4.2. Europe Rare Disease Genetic Testing Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific Rare Disease Genetic Testing by Countries
7.5.1. Asia-Pacific Rare Disease Genetic Testing Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific Rare Disease Genetic Testing Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America Rare Disease Genetic Testing by Countries
7.6.1. South America Rare Disease Genetic Testing Revenue and Growth Rate (2017-2021)
7.6.2. South America Rare Disease Genetic Testing Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa Rare Disease Genetic Testing by Countries
7.7.1. Middle East and Africa Rare Disease Genetic Testing Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa Rare Disease Genetic Testing Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. Quest Diagnostics Inc.
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Centogene N.V.
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Invitae Corporation
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. 3billion, Inc.
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Arup Laboratories
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Eurofins Scientific
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Strand Life Sciences
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Ambry Genetics
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Perkin Elmer, Inc.
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
8.10. Macrogen, Inc.
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Financial Overview
9. Rare Disease Genetic Testing Market Forecast (2022-2027)
9.1. Global Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. Rare Disease Genetic Testing Market Forecast by Regions (2022-2027)
9.2.1. North America Rare Disease Genetic Testing Market Forecast (2022-2027)
9.2.1.1. United States Rare Disease Genetic Testing Market Forecast (2022-2027)
9.2.1.2. Canada Rare Disease Genetic Testing Market Forecast (2022-2027)
9.2.1.3. Mexico Rare Disease Genetic Testing Market Forecast (2022-2027)
9.2.2. Europe Rare Disease Genetic Testing Market Forecast (2022-2027)
9.2.2.1. Germany Rare Disease Genetic Testing Market Forecast (2022-2027)
9.2.2.2. France Rare Disease Genetic Testing Market Forecast (2022-2027)
9.2.2.3. UK Rare Disease Genetic Testing Market Forecast (2022-2027)
9.2.2.4. Russia Rare Disease Genetic Testing Market Forecast (2022-2027)
9.2.2.5. Italy Rare Disease Genetic Testing Market Forecast (2022-2027)
9.2.2.6. Rest of Europe Rare Disease Genetic Testing Market Forecast (2022-2027)
9.2.3. Asia-Pacific Rare Disease Genetic Testing Market Forecast (2022-2027)
9.2.3.1. China Rare Disease Genetic Testing Market Forecast (2022-2027)
9.2.3.2. Japan Rare Disease Genetic Testing Market Forecast (2022-2027)
9.2.3.3. Korea Rare Disease Genetic Testing Market Forecast (2022-2027)
9.2.3.4. India Rare Disease Genetic Testing Market Forecast (2022-2027)
9.2.3.5. Southeast Asia Rare Disease Genetic Testing Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific Rare Disease Genetic Testing Market Forecast (2022-2027)
9.2.4. South America Rare Disease Genetic Testing Market Forecast (2022-2027)
9.2.4.1. Brazil Rare Disease Genetic Testing Market Forecast (2022-2027)
9.2.4.2. Argentina Rare Disease Genetic Testing Market Forecast (2022-2027)
9.2.4.3. Columbia Rare Disease Genetic Testing Market Forecast (2022-2027)
9.2.4.4. Rest of South America Rare Disease Genetic Testing Market Forecast (2022-2027)
9.2.5. Middle East and Africa Rare Disease Genetic Testing Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia Rare Disease Genetic Testing Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates Rare Disease Genetic Testing Market Forecast (2022-2027)
9.2.5.3. Egypt Rare Disease Genetic Testing Market Forecast (2022-2027)
9.2.5.4. Nigeria Rare Disease Genetic Testing Market Forecast (2022-2027)
9.2.5.5. South Africa Rare Disease Genetic Testing Market Forecast (2022-2027)
9.2.5.6. Turkey Rare Disease Genetic Testing Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa Rare Disease Genetic Testing Market Forecast (2022-2027)
9.3. Rare Disease Genetic Testing Market Forecast by Technology (2022-2027)
9.3.1. Rare Disease Genetic Testing Forecast by Technology (2022-2027)
9.3.2. Rare Disease Genetic Testing Market Share Forecast by Technology (2022-2027)
9.4. Rare Disease Genetic Testing Market Forecast by Applications (2022-2027)
9.4.1. Rare Disease Genetic Testing Forecast by Applications (2022-2027)
9.4.2. Rare Disease Genetic Testing Market Share Forecast by Applications (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Rare Disease Genetic Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Rare Disease Genetic Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Rare Disease Genetic Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Rare Disease Genetic Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Rare Disease Genetic Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Rare Disease Genetic Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Rare Disease Genetic Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Rare Disease Genetic Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Rare Disease Genetic Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Rare Disease Genetic Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Rare Disease Genetic Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Rare Disease Genetic Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Rare Disease Genetic Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Rare Disease Genetic Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Rare Disease Genetic Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Rare Disease Genetic Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Rare Disease Genetic Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Rare Disease Genetic Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Rare Disease Genetic Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Rare Disease Genetic Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Rare Disease Genetic Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Rare Disease Genetic Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Rare Disease Genetic Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Rare Disease Genetic Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Rare Disease Genetic Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Rare Disease Genetic Testing Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Rare Disease Genetic Testing Revenue and Revenue Share by Technology (2017-2019)
Figure Global Next-Generation Sequencing (NGS) Revenue and Growth Rate (2017-2019)
Figure Global Array Technology Revenue and Growth Rate (2017-2019)
Figure Global PCR-based Testing Revenue and Growth Rate (2017-2019)
Figure Global FISH Revenue and Growth Rate (2017-2019)
Figure Global Sanger Sequencing Revenue and Growth Rate (2017-2019)
Figure Global Karyotyping Revenue and Growth Rate (2017-2019)
Table Global Rare Disease Genetic Testing Revenue and Revenue Share by Applications (2017-2019)
Figure Global Research Laboratories & CROs Revenue and Growth Rate (2017-2019)
Figure Global Diagnostic Laboratories Revenue and Growth Rate (2017-2019)
Figure Global Hospitals & Clinics Revenue and Growth Rate (2017-2019)
Table Global Rare Disease Genetic Testing Revenue by Regions (2017-2019)
Figure North America Rare Disease Genetic Testing Growth Rate (2017-2019)
Figure North America Rare Disease Genetic Testing Revenue and Growth Rate (2017-2019)
Figure North America Rare Disease Genetic Testing by Countries (2017-2019)
Figure North America Rare Disease Genetic Testing Revenue (Million USD) by Countries (2017-2019)
Figure United States Rare Disease Genetic Testing Growth Rate (2017-2019)
Figure United States Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Rare Disease Genetic Testing Growth Rate (2017-2019)
Figure Canada Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Rare Disease Genetic Testing Growth Rate (2017-2019)
Figure Mexico Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Rare Disease Genetic Testing Growth Rate (2017-2019)
Figure Europe Rare Disease Genetic Testing Revenue and Growth Rate (2017-2019)
Figure Europe Rare Disease Genetic Testing by Countries (2017-2019)
Figure Europe Rare Disease Genetic Testing Revenue (Million USD) by Countries (2017-2019)
Figure Germany Rare Disease Genetic Testing Growth Rate (2017-2019)
Figure Germany Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Rare Disease Genetic Testing Growth Rate (2017-2019)
Figure France Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Rare Disease Genetic Testing Growth Rate (2017-2019)
Figure UK Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Rare Disease Genetic Testing Growth Rate (2017-2019)
Figure Russia Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Rare Disease Genetic Testing Growth Rate (2017-2019)
Figure Italy Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Rare Disease Genetic Testing Growth Rate (2017-2019)
Figure Rest of Europe Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Rare Disease Genetic Testing Growth Rate (2017-2019)
Figure Asia-Pacific Rare Disease Genetic Testing Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Rare Disease Genetic Testing by Countries (2017-2019)
Figure Asia-Pacific Rare Disease Genetic Testing Revenue (Million USD) by Countries (2017-2019)
Figure China Rare Disease Genetic Testing Growth Rate (2017-2019)
Figure China Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Rare Disease Genetic Testing Growth Rate (2017-2019)
Figure Japan Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Rare Disease Genetic Testing Growth Rate (2017-2019)
Figure Korea Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Rare Disease Genetic Testing Growth Rate (2017-2019)
Figure India Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Rare Disease Genetic Testing Growth Rate (2017-2019)
Figure Southeast Asia Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Rare Disease Genetic Testing Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Rare Disease Genetic Testing Growth Rate (2017-2019)
Figure South America Rare Disease Genetic Testing Revenue and Growth Rate (2017-2019)
Figure South America Rare Disease Genetic Testing by Countries (2017-2019)
Figure South America Rare Disease Genetic Testing Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Rare Disease Genetic Testing Growth Rate (2017-2019)
Figure Brazil Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Rare Disease Genetic Testing Growth Rate (2017-2019)
Figure Argentina Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Rare Disease Genetic Testing Growth Rate (2017-2019)
Figure Columbia Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Rare Disease Genetic Testing Growth Rate (2017-2019)
Figure Rest of South America Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Rare Disease Genetic Testing Growth Rate (2017-2019)
Figure Middle East and Africa Rare Disease Genetic Testing Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Rare Disease Genetic Testing by Countries (2017-2019)
Figure Middle East and Africa Rare Disease Genetic Testing Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Rare Disease Genetic Testing Growth Rate (2017-2019)
Figure Saudi Arabia Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Rare Disease Genetic Testing Growth Rate (2017-2019)
Figure United Arab Emirates Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Rare Disease Genetic Testing Growth Rate (2017-2019)
Figure Egypt Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Rare Disease Genetic Testing Growth Rate (2017-2019)
Figure Nigeria Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Rare Disease Genetic Testing Growth Rate (2017-2019)
Figure South Africa Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Rare Disease Genetic Testing Growth Rate (2017-2019)
Figure Turkey Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Rare Disease Genetic Testing Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Table Quest Diagnostics Inc. Rare Disease Genetic Testing Financial Overview
Table Centogene N.V. Rare Disease Genetic Testing Financial Overview
Table Invitae Corporation Rare Disease Genetic Testing Financial Overview
Table 3billion, Inc. Rare Disease Genetic Testing Financial Overview
Table Arup Laboratories Rare Disease Genetic Testing Financial Overview
Table Eurofins Scientific Rare Disease Genetic Testing Financial Overview
Table Strand Life Sciences Rare Disease Genetic Testing Financial Overview
Table Ambry Genetics Rare Disease Genetic Testing Financial Overview
Table Perkin Elmer, Inc. Rare Disease Genetic Testing Financial Overview
Table Macrogen, Inc. Rare Disease Genetic Testing Financial Overview
Figure Global Rare Disease Genetic Testing Revenue (Millions USD) and Growth Rate (2019-2027)
Table Rare Disease Genetic Testing Market Forecast by Regions (2019-2027)
Figure North America Rare Disease Genetic Testing Market Forecast (2019-2027)
Figure United States Rare Disease Genetic Testing Market Forecast (2019-2027)
Figure Canada Rare Disease Genetic Testing Market Forecast (2019-2027)
Figure Mexico Rare Disease Genetic Testing Market Forecast (2019-2027)
Figure Europe Rare Disease Genetic Testing Market Forecast (2019-2027)
Figure Germany Rare Disease Genetic Testing Market Forecast (2019-2027)
Figure France Rare Disease Genetic Testing Market Forecast (2019-2027)
Figure UK Rare Disease Genetic Testing Market Forecast (2019-2027)
Figure Russia Rare Disease Genetic Testing Market Forecast (2019-2027)
Figure Italy Rare Disease Genetic Testing Market Forecast (2019-2027)
Figure Rest of Europe Rare Disease Genetic Testing Market Forecast (2019-2027)
Figure Asia-Pacific Rare Disease Genetic Testing Market Forecast (2019-2027)
Figure China Rare Disease Genetic Testing Market Forecast (2019-2027)
Figure Japan Rare Disease Genetic Testing Market Forecast (2019-2027)
Figure Korea Rare Disease Genetic Testing Market Forecast (2019-2027)
Figure India Rare Disease Genetic Testing Market Forecast (2019-2027)
Figure Southeast Asia Rare Disease Genetic Testing Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Rare Disease Genetic Testing Market Forecast (2019-2027)
Figure South America Rare Disease Genetic Testing Market Forecast (2019-2027)
Figure Brazil Rare Disease Genetic Testing Market Forecast (2019-2027)
Figure Argentina Rare Disease Genetic Testing Market Forecast (2019-2027)
Figure Columbia Rare Disease Genetic Testing Market Forecast (2019-2027)
Figure Rest of South America Rare Disease Genetic Testing Market Forecast (2019-2027)
Figure Middle East and Africa Rare Disease Genetic Testing Market Forecast (2019-2027)
Figure Saudi Arabia Rare Disease Genetic Testing Market Forecast (2019-2027)
Figure United Arab Emirates Rare Disease Genetic Testing Market Forecast (2019-2027)
Figure Egypt Rare Disease Genetic Testing Market Forecast (2019-2027)
Figure Nigeria Rare Disease Genetic Testing Market Forecast (2019-2027)
Figure South Africa Rare Disease Genetic Testing Market Forecast (2019-2027)
Figure Turkey Rare Disease Genetic Testing Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Rare Disease Genetic Testing Market Forecast (2019-2027)
Figure Global Rare Disease Genetic Testing Forecast by Technology (2019-2027)
Figure Global Rare Disease Genetic Testing Market Share Forecast by Technology (2019-2027)
Figure Global Rare Disease Genetic Testing Forecast by Technology (2019-2027)
Figure Global Rare Disease Genetic Testing Forecast by Applications (2019-2027)
Figure Global Rare Disease Genetic Testing Market Share Forecast by Applications (2019-2027)
Figure Global Rare Disease Genetic Testing Forecast by Applications (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|